Australian banknote manufacturer CCL Secure has successfully blocked British rival De La Rue International from registering a patent for a banknote security device.
A court has struck out defamation claims brought by embattled Quintis founder Frank Wilson against the company’s former directors over ASX statements he alleges suggested he knew about the company’s termination of a supply contract with Nestle’s dermatology unit, Galderma Laboratories.
The Federal Court has ordered Queensland online news company Touchpoint Media to pay over $300,000 in wages owed to journalists and slapped the company with a $265,000 fine.
The litigation funder that unsuccessfully sought to block a shareholder from opposing a $64 million class action settlement over the collapse of Banksia Securities is not on the hook for indemnity costs despite bringing the injunction with an ulterior motive.
A judge has struck out part of a class action against the Commonwealth Bank of Australia that alleges it kept investors in the dark about deficiencies in its systems for monitoring money laundering and terrorism financing risks, saying it wasn’t clear what the bank was expected to disclose.
Online lender Prospa has agreed to alter unfair terms in its standard form small business loan contracts, after it delayed a planned float due to concerns raised by ASIC about its loan terms.
A year after the Federal Court issued its important ruling on competing class actions and foreshadowed orders prohibiting duplicative legal fees, the company at the centre of the proceedings — organic baby food maker Bellamy’s — has called on the court to make good on its promise about costs.
Cereal giant Sanitarium and retailer Rebel Sports are challenging a decision dismissing proceedings against a UK marketing company amid a contractual dispute over a recent joint promotional campaign.
Volkswagen has agreed to offer refunds or replacements to consumers if a defect makes a car un-drivable within the first 60 days after purchase without requiring proof of a major failure.
ObjectiVision has presented a “limited” and “debatable” case that its source code for a glaucoma testing device was copied, the Federal Court heard Thursday as the trial in a four-year spat with the University of Sydney over IP rights came to a close.